# FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

> **NCT02578732** · PHASE2 · COMPLETED · sponsor: **Brown University** · enrollment: 28 (actual)

## Conditions studied

- Locally Advanced Pancreatic Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** FOLFOXA

## Key facts

- **NCT ID:** NCT02578732
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-12
- **Primary completion:** 2019-12-18
- **Final completion:** 2022-03-16
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578732, "FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02578732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*